QIPT — Quipt Home Medical Income Statement
0.000.00%
- $93.55m
- $178.82m
- $245.92m
- 56
- 93
- 17
- 56
Annual income statement for Quipt Home Medical, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | C2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 72.6 | 102 | 140 | 212 | 246 |
Cost of Revenue | |||||
Gross Profit | 52.7 | 74.2 | 107 | 154 | 177 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 72 | 104 | 135 | 209 | 245 |
Operating Profit | 0.658 | -1.46 | 4.45 | 2.82 | 1.11 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.58 | -9.33 | 2.94 | -2.7 | -6.65 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.7 | -6.17 | 4.84 | -2.78 | -6.76 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.57 | -6.17 | 4.84 | -2.78 | -6.76 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.57 | -6.17 | 4.84 | -2.78 | -6.76 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.163 | -0.2 | 0.153 | -0.051 | -0.155 |